TOKYO–(BUSINESS WIRE)–3D Investment Partners Pte. Ltd. (together with the Fund, “3D” or the “Company”) provides discretionary investment management services to an investment fund which is a shareholder of Toho Holdings Co., Ltd. (TOKYO: 8129, “Toho HD”) (collectively referred to “3D” or “we” together with the investment fund) sent an open letter to the outside directors … [Read more…]

CHICAGO–(BUSINESS WIRE)–Cosan, a connected chronic care management company helping providers extend care beyond the clinic, today announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and Specialty Alliance, the nation’s largest provider of specialty care and a long-standing Cosan partner. The investment accelerates Cosan’s expansion of its AI-enabled, human-led virtual care … [Read more…]

SHORT HILLS, N.J.–(BUSINESS WIRE)–#healthcare–FemHealth Ventures, a leading women’s health-focused venture capital firm, a top-decile performer across DPI and IRR for Fund I, announced the close of FemHealth Ventures Fund II at $65 million. The oversubscribed raise brings the firm’s assets under management to $100 million across two funds and further solidifies FemHealth Ventures’ position as … [Read more…]

MADISON, Wis.–(BUSINESS WIRE)–Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), today announced the expanded implementation of Banjo Health. Banjo is an advanced automation platform with artificial intelligence (AI) capabilities designed to modernize and simplify prior authorization workflows that are central to pharmacy benefits management. Now implemented across employer and health plan … [Read more…]

Retailer and Market Demands Drive Rapid Traceability Adoption SALT LAKE CITY–(BUSINESS WIRE)–ReposiTrak (NYSE: TRAK), the industry leader in food traceability and regulatory compliance, announced that the push for traceability is now being driven by market forces rather than federal timelines. During a recent MorningNewsBeat interview, ReposiTrak Chairman and CEO Randy Fields and Affiliated Foods, Inc., … [Read more…]

TAIPEI, Taiwan–(BUSINESS WIRE)–Taiwan has achieved the World Health Organization’s (WHO) goal of eliminating Hepatitis C by 2025, reaching this milestone ahead of the global timeline. Through cross-sectoral collaboration from central to local levels, the nation has established an integrated strategy covering prevention, screening, and treatment. The results have been outstanding, with all key indicators surpassing … [Read more…]

Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of action and improvement of itch and sleep disturbance in patients with moderate-to-severe atopic dermatitis and prurigo nodularis1 Significant improvements in itch were observed as early as … [Read more…]

Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials showing significantly lower rate of annualized asthma exacerbations in patients receiving depemokimab versus placebo SWIFT data included reduction in exacerbations requiring hospitalization and/or emergency department visits with depemokimab An … [Read more…]

New publication demonstrates that insitro’s POSH platform — integrating pooled CRISPR screening and self-supervised deep learning — successfully breaks the historic compromise between scale and depth to more rapidly identify novel therapeutic targets SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–insitro, the AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications … [Read more…]

MIAMI–(BUSINESS WIRE)–Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (Nasdaq: PETS) (“PetMeds”) for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivered to … [Read more…]